Assessment of trajectories of high-risk drug users: incidence of abuse and impact on morbidity and mortality (METEOR)

Study identification

• PURI:
  https://redirect.ema.europa.eu/resource/1000000248
• EU PAS number:
  EUPAS1000000248
• Study ID:
  1000000248
• Official title and acronym:
  Assessment of trajectories of high-risk drug users: incidence of abuse and impact on morbidity and mortality (METEOR)
• DARWIN EU® study:
  No
• Study countries:
  France
• Study status:
  Planned

Research institutions and networks

Institutions

Department of Clinical Pharmacology and Pharmacosurveillance, University Hospital of Marseille

France

Pharmacologie En Population cohorteS biobanqueS (PEPSS), Hopitaux de Toulouse

France

Study timelines

Date when funding contract was signed

Actual: 20/12/2021

Study start date

Planned: 01/01/2022

Date of final study report

Planned: 31/12/2024

Sources of funding

National competent authority (NCAs)

More details on funding

EPI-PHARE/ANSM

Study protocol

Initial protocol

MICALLEF projet METEOR - epi-phare document_scientifique_aap2021.pdf

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable